ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CEPH Cephalon (MM)

81.49
0.00 (0.00%)
18 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Cephalon (MM) NASDAQ:CEPH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 81.49 0 01:00:00

CENTURYTEL INC (CTL) - Profit Tracks

07/09/2011 1:00am

Zacks


Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List - Stocks to Sell Now by 80% annually (+2% versus +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid.

Here is a synopsis of why MOLX and CTL have a Zacks Rank of #5 (Strong Sell) and should most likely be sold or avoided for the next one to three months. Note that a #5 Strong Sell rating is applied to 5% of all the stocks in the Zacks Rank universe:

Molex Incorporated (MOLX)announced fourth-quarter profit of 44 cents per share on August 3 that missed analysts? expectations by 4.35%. The Zacks Consensus Estimate for the current year slid to $1.82 per share from $1.85 per share in the last 30 days as next year?s estimate dipped 1 cent per share to $2.09 per share in that time span.

CenturyLink, Inc. (CTL) posted a second-quarter profit of 64 cents per share on August 3, which came in 2 cents wider than the average forecast. The Zacks Consensus Estimate for the full year fell to $1.70 per share from $1.74 per share over the past month. For 2012, analysts expect a profit of $1.74 per share, compared to last month?s projection for a profit of $2.03 per share.

Here is a synopsis of why NILE and CEPH have a Zacks Rank of 4 (Sell) and should also most likely be sold or avoided for the next one to three months. Note that a #4 Sell rating is applied to 15% of all the stocks ranked by Zacks;

Blue Nile, Inc. (NILE) second-quarter profit of 19 cents per share, posted on August 4, lagged analysts? projections by 13.64%. Estimate for current year slid 2 cent per share to $1.02 per share over a month as next year?s estimate dipped 4 cents per share to $1.14 per share in that time span.

Cephalon, Inc. (CEPH) reported a second-quarter profit of $1.62 per share on August 2 that fell 22.12% short of the Zacks Consensus Estimate. The full-year average forecast is currently $8.18 per share, compared with last two month?s projection of $8.34 per share. Next year?s forecast dropped to $5.27 per share from $5.47 per share in the same period.
 
CEPHALON INC (CEPH): Free Stock Analysis Report
 
CENTURYLINK INC (CTL): Free Stock Analysis Report
 
MOLEX INC (MOLX): Free Stock Analysis Report
 
BLUE NILE INC (NILE): Free Stock Analysis Report
 
Zacks Investment Research

1 Year Cephalon Chart

1 Year Cephalon Chart

1 Month Cephalon Chart

1 Month Cephalon Chart